Clinical Outcomes and Microbiological Characteristics of Sequence Type 11 Klebsiella pneumoniae Infection
- PMID: 35652076
- PMCID: PMC9149164
- DOI: 10.3389/fmed.2022.889020
Clinical Outcomes and Microbiological Characteristics of Sequence Type 11 Klebsiella pneumoniae Infection
Abstract
Background: Sequence type 11 (ST11) Klebsiella pneumoniae (Kp) is highly prevalent in China and is a typical sequence type among KPC-producing isolates. This study aimed to evaluate the clinical outcomes and microbiological features of ST11 Kp infections.
Methods: A retrospective cohort study was conducted at Peking University Third Hospital from January 2017 to March 2021. Clinical data were collected from medical records. Antimicrobial susceptibility testing and string tests were performed. Whole-genome sequencing was used to analyze the capsular serotypes, detect virulence-associated genes, and perform multilocus sequence typing. The risk of all-cause mortality in ST11 Kp-infected patients was compared to that in non-ST11 Kp-infected patients.
Results: From 139 patients infected with Kp, 49 ST11 Kp (35.3%) strains were isolated. The Charlson comorbidity index in the ST11 group was higher than that in the non-ST11 group (3.94 ± 1.59 vs. 2.41 ± 1.54, P = 0.001). A greater number of ST11 Kp-infected patients required ICU admission (46.9 vs. 16.7%, P < 0.001) and mechanical ventilation (28.6 vs. 10.0%, P = 0.005). All ST11 isolates presented a multidrug-resistant (MDR) phenotype, and twenty-nine (59.2%) hypervirulent Kp (hvKp) were identified. Twenty-four ST11 strains presented with hypermucoviscosity. The presence of capsular types K47 and K64 was frequent in the ST11 Kp strains (P < 0.001). The key virulence-associated genes rmpA, rmpA2, iucA, iroB, and peg344 were present in 26.5, 42.9, 59.2, 0, and 26.5% of the isolates, respectively, in the ST11 group. Twenty-one ST11 isolates harbored the combination of iucA+rmpA2. The 30-day mortality rate and sequential organ failure assessment (SOFA) score were significantly higher in ST11 Kp-infected patients than in non-ST11 Kp-infected patients (P < 0.01). ST11 Kp infection appeared to be an independent risk factor for mortality in ST11 Kp-infected patients.
Conclusions: A high prevalence of the ST11 clone was found in the hospital, which accounted for elevated antimicrobial resistance and exhibited great molecularly inferred virulence. Patients with ST11 Kp infection had a tendency toward increased 30-day mortality and SOFA scores. ST11 Kp infection was an independent risk factor for mortality, suggesting that enhanced surveillance and management are essential.
Keywords: Klebsiella pneumoniae; ST11; multidrug resistance; risk factor; virulence.
Copyright © 2022 Yang, Wu, Liu, Zheng, Wu, Wu, Yi, Lu and Shen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Clinical Outcomes, Microbiological Characteristics and Risk Factors for Difficult-to-Treat Resistance to Klebsiella pneumoniae Infection.Infect Drug Resist. 2022 Oct 17;15:5959-5969. doi: 10.2147/IDR.S377064. eCollection 2022. Infect Drug Resist. 2022. PMID: 36262596 Free PMC article.
-
Infection with Carbapenem-resistant Hypervirulent Klebsiella Pneumoniae: clinical, virulence and molecular epidemiological characteristics.Antimicrob Resist Infect Control. 2023 Nov 13;12(1):124. doi: 10.1186/s13756-023-01331-y. Antimicrob Resist Infect Control. 2023. PMID: 37953357 Free PMC article.
-
Convergence of two serotypes within the epidemic ST11 KPC-producing Klebsiella pneumoniae creates the "Perfect Storm" in a teaching hospital.BMC Genomics. 2022 Oct 7;23(1):693. doi: 10.1186/s12864-022-08924-8. BMC Genomics. 2022. PMID: 36207674 Free PMC article.
-
Phenotypic and Genomic Characterization of Virulence Heterogeneity in Multidrug-Resistant ST11 Klebsiella pneumoniae During Inter-Host Transmission and Evolution.Infect Drug Resist. 2020 Jun 10;13:1713-1721. doi: 10.2147/IDR.S243836. eCollection 2020. Infect Drug Resist. 2020. PMID: 32606821 Free PMC article.
-
Emergence of Hypervirulent ST11-K64 Klebsiella pneumoniae Poses a Serious Clinical Threat in Older Patients.Front Public Health. 2022 Mar 4;10:765624. doi: 10.3389/fpubh.2022.765624. eCollection 2022. Front Public Health. 2022. PMID: 35309213 Free PMC article.
Cited by
-
Clinical Characteristics, Virulence Profile, and Molecular Epidemiology of Klebsiella pneumoniae Infections in Kidney Transplant Recipients.Infect Drug Resist. 2025 Mar 6;18:1303-1311. doi: 10.2147/IDR.S506794. eCollection 2025. Infect Drug Resist. 2025. PMID: 40065763 Free PMC article.
-
Clinical Outcomes, Microbiological Characteristics and Risk Factors for Difficult-to-Treat Resistance to Klebsiella pneumoniae Infection.Infect Drug Resist. 2022 Oct 17;15:5959-5969. doi: 10.2147/IDR.S377064. eCollection 2022. Infect Drug Resist. 2022. PMID: 36262596 Free PMC article.
-
ST218 Klebsiella pneumoniae became a high-risk clone for multidrug resistance and hypervirulence.BMC Microbiol. 2024 Feb 12;24(1):56. doi: 10.1186/s12866-024-03205-8. BMC Microbiol. 2024. PMID: 38347440 Free PMC article.
-
Antimicrobial resistance in hypermucoviscous and non-hypermucoviscous Klebsiella pneumoniae: a systematic review and meta-analysis.Emerg Microbes Infect. 2025 Dec;14(1):2438657. doi: 10.1080/22221751.2024.2438657. Epub 2024 Dec 16. Emerg Microbes Infect. 2025. PMID: 39629681 Free PMC article.
-
Successful treatment of acute respiratory distress syndrome caused by hypervirulent Klebsiella pneumoniae with extracorporeal membrane oxygenation and continuous renal replacement therapy: A case report and literature review.Front Med (Lausanne). 2022 Aug 24;9:936927. doi: 10.3389/fmed.2022.936927. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36091705 Free PMC article.
References
LinkOut - more resources
Full Text Sources